173 related articles for article (PubMed ID: 30074149)
1. Enhanced Response of Acute Monocytic Leukemia Cells to Low-dose Cytarabine by 1,25-dihydroxyvitamin D3.
Guo H; Lin SY; Ren WX; Lei Q; Chen ZC; Zhang L; Li QB
Curr Med Sci; 2018 Feb; 38(1):35-42. PubMed ID: 30074149
[TBL] [Abstract][Full Text] [Related]
2. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
3. [Efficiency of GHA priming therapy on patients with acute monocytic leukemia and its mechanism].
Ji YY; Zhang WG; Chen YX; Zhao XM; He AL; Liu J; Wang JL; Wang FX; Zhang PY; Zhang WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):213-8. PubMed ID: 20137150
[TBL] [Abstract][Full Text] [Related]
4. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
[TBL] [Abstract][Full Text] [Related]
5. The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine.
Walsby EJ; Coles SJ; Knapper S; Burnett AK
Haematologica; 2011 Mar; 96(3):393-9. PubMed ID: 21134979
[TBL] [Abstract][Full Text] [Related]
6. MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine.
Lu JW; Lin YM; Lai YL; Chen CY; Hu CY; Tien HF; Ou DL; Lin LI
Med Oncol; 2015 Jul; 32(7):206. PubMed ID: 26087957
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C.
Zheng R; Wang X; Studzinski GP
J Steroid Biochem Mol Biol; 2015 Apr; 148():132-7. PubMed ID: 25448741
[TBL] [Abstract][Full Text] [Related]
8. The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents.
Shen X; Xiong GL; Jing Y; Xiao H; Cui Y; Zhang YF; Shan YJ; Xing S; Yang M; Liu XL; Dong B; Wang LS; Luo QL; Yu ZY; Cong YW
Cancer Lett; 2015 Jan; 356(2 Pt B):686-96. PubMed ID: 25449427
[TBL] [Abstract][Full Text] [Related]
9. Butyrate increases apoptosis induced by different antineoplastic drugs in monocytic leukemia cells.
Ramos MG; Rabelo FL; Brumatti G; Bueno-da-Silva AE; Amarante-Mendes GP; Alvarez-Leite JI
Chemotherapy; 2004 Nov; 50(5):221-8. PubMed ID: 15528887
[TBL] [Abstract][Full Text] [Related]
10. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression.
Clark CS; Konyer JE; Meckling KA
Exp Cell Res; 2004 Mar; 294(1):301-11. PubMed ID: 14980523
[TBL] [Abstract][Full Text] [Related]
11. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
[TBL] [Abstract][Full Text] [Related]
12. Cell differentiation and therapeutic effect of low doses of cytosine arabinoside in human myeloid leukemia.
Michalewicz R; Lotem J; Sachs L
Leuk Res; 1984; 8(5):783-90. PubMed ID: 6593509
[TBL] [Abstract][Full Text] [Related]
13. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
Kasukabe T; Honma Y; Hozumi M; Suda T; Nishii Y
Cancer Res; 1987 Jan; 47(2):567-72. PubMed ID: 3466692
[TBL] [Abstract][Full Text] [Related]
14. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG
Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
Wang X; Harrison JS; Studzinski GP
J Steroid Biochem Mol Biol; 2016 Nov; 164():72-78. PubMed ID: 26319201
[TBL] [Abstract][Full Text] [Related]
16. The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells.
Walsby EJ; Lazenby M; Pepper CJ; Knapper S; Burnett AK
Br J Haematol; 2013 Apr; 161(1):57-67. PubMed ID: 23356405
[TBL] [Abstract][Full Text] [Related]
17. Ara-C and anti-CD47 antibody combination therapy eliminates acute monocytic leukemia THP-1 cells in vivo and in vitro.
Wang Y; Yin C; Feng L; Wang C; Sheng G
Genet Mol Res; 2015 May; 14(2):5630-41. PubMed ID: 26125761
[TBL] [Abstract][Full Text] [Related]
18. Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia.
Sharabani H; Izumchenko E; Wang Q; Kreinin R; Steiner M; Barvish Z; Kafka M; Sharoni Y; Levy J; Uskokovic M; Studzinski GP; Danilenko M
Int J Cancer; 2006 Jun; 118(12):3012-21. PubMed ID: 16395705
[TBL] [Abstract][Full Text] [Related]
19. Genetic inhibition of vascular endothelial growth factor receptor-1 significantly inhibits the migration and proliferation of leukemia cells and increases their sensitivity to chemotherapy.
Xiu B; Zhang W; Huang B; Chen J; Lu H; Fu J; Xiong H; Liang A
Oncol Rep; 2013 May; 29(5):2030-8. PubMed ID: 23503608
[TBL] [Abstract][Full Text] [Related]
20. Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia.
Gaur T; Ali A; Sharma D; Gupta SK; Gota V; Bagal B; Platzbeckar U; Mishra R; Dutt A; Khattry N; Mills K; Hassan MI; Sandur S; Hasan SK
Cell Signal; 2024 Feb; 114():111004. PubMed ID: 38048856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
